Cardinal Health, Inc. vs Eli Lilly & Co.
CAH vs LLY — side-by-side comparison from reported financials. CAH leads 5, LLY leads 6 of 11 comparable metrics.
Cardinal Health, Inc.
CAH · Healthcare
$237.57-0.58%Solid
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | CAH | LLY |
|---|---|---|
| Price | $237.57 | $1 177.20 |
| Market cap | $55.0B | $1.05T |
| Revenue (TTM) | $254B | $79.7B |
| Revenue growth | +7.4% | +31.7% |
| Net margin | 0.7% | 33.5% |
| Free cash flow | $4.53B | $18.2B |
| Net cash (debt) | ($5.14B) | ($35.2B) |
| 1-year price return | +51.1% | +37.6% |
| P/E | 32.1 | 41.6 |
| P/E vs own history (cheap-side %) | 26% | 88% |
| Dividend yield | 0.89% | 0.52% |
| Return on equity | 37% | 93% |
| Altman Z-score | 5.09 | 7.10 |
| CV checks passed | 11 of 11 | 11 of 11 |
| Employees | 63,900 | 50,000 |
Full résumé-style profiles: CAH CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.